| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.89B | 1.82B | 2.13B | 2.01B | 1.72B | 1.54B |
| Gross Profit | 1.11B | 1.06B | 1.13B | 1.08B | 917.81M | 823.28M |
| EBITDA | 108.52M | 89.58M | 53.12M | 161.23M | 169.71M | 116.49M |
| Net Income | -14.15M | -28.50M | -65.90M | 42.12M | 32.80M | 23.65M |
Balance Sheet | ||||||
| Total Assets | 1.97B | 2.01B | 2.17B | 2.29B | 2.03B | 1.66B |
| Cash, Cash Equivalents and Short-Term Investments | 48.47M | 73.95M | 149.90M | 229.43M | 39.34M | 17.13M |
| Total Debt | 719.34M | 816.03M | 923.46M | 1.00B | 953.40M | 578.11M |
| Total Liabilities | 1.12B | 1.19B | 1.34B | 1.39B | 1.26B | 918.24M |
| Stockholders Equity | 850.58M | 816.33M | 829.42M | 901.11M | 776.44M | 743.15M |
Cash Flow | ||||||
| Free Cash Flow | 56.74M | 38.14M | 58.26M | 5.65M | 63.76M | 2.13M |
| Operating Cash Flow | 144.70M | 133.65M | 173.03M | 119.20M | 165.08M | 106.63M |
| Investing Cash Flow | -90.97M | -96.09M | -115.82M | -110.89M | -100.63M | -104.22M |
| Financing Cash Flow | -184.73M | -113.34M | -136.81M | -84.56M | -42.14M | 10.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $23.21B | 19.84 | 48.52% | ― | 2.94% | 4.57% | |
77 Outperform | $6.76B | 20.82 | 22.92% | 2.79% | 10.93% | -10.89% | |
73 Outperform | $1.50B | 8.17 | 28.94% | ― | -0.38% | 35.78% | |
73 Outperform | $1.61B | 35.94 | 10.36% | ― | 10.68% | 37.84% | |
63 Neutral | $5.57B | 8.03 | ― | 2.96% | -0.18% | -18.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | $2.02B | -139.41 | -1.77% | ― | -7.25% | 82.63% |
National Vision Holdings’ recent earnings call painted a picture of strong financial performance and strategic initiatives that are driving growth, particularly in the managed care segment. The company is making significant strides in brand revitalization and operational efficiency, although challenges persist in the cash pay segment, and there is cautious guidance for the second half of the year.
National Vision Holdings, Inc. is a leading optical retail company in the United States, operating over 1,200 stores across various brands, including America’s Best Contacts & Eyeglasses and Eyeglass World, with a mission to provide affordable and accessible eye care and eyewear. In the second quarter of 2025, National Vision reported a 7.7% increase in net revenue, reaching $486.4 million, and a 6.5% growth in comparable store sales, marking the tenth consecutive quarter of positive growth. The company also saw a significant improvement in profitability, with adjusted operating income rising by 69.1% to $23.8 million and adjusted diluted EPS increasing to $0.18. Key financial highlights include a 3.5% increase in costs applicable to revenue and a 6.8% rise in SG&A expenses, with overall store count growing by 2.0%. Looking ahead, National Vision has raised its fiscal 2025 outlook, reflecting confidence in its strategic direction, with plans to continue leveraging brand advertising and cost management to drive sustainable growth and long-term value for shareholders.
On August 1, 2025, National Vision Holdings expanded its Board of Directors to eleven members, appointing Alex Wilkes as a new director. This appointment is part of a CEO succession plan where Reade Fahs will become Executive Chairman, and Alex Wilkes will succeed him as CEO, indicating a strategic leadership transition within the company.
The most recent analyst rating on (EYE) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on National Vision Holdings stock, see the EYE Stock Forecast page.